We hope you’ll join us for our virtual R&D Day on March 5 at 6am PT/ 9am ET. During this webcast we’ll discuss our #clinical program progress and our lead investigational CD47-blocker, evorpacept, and share business and financial updates. Register here: bit.ly/3Qox18L #CD47 #Oncology #InvestorDay
